Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
3.92
-0.23 (-5.54%)
At close: Jul 03, 2025, 3:59 PM
4.49
14.54%
After-hours: Jul 03, 2025, 04:59 PM EDT
-5.54% (1D)
| Bid | 4.49 |
| Market Cap | 12.41M |
| Revenue (ttm) | 1M |
| Net Income (ttm) | -13.29M |
| EPS (ttm) | -12.07 |
| PE Ratio (ttm) | -0.32 |
| Forward PE | -0.04 |
| Analyst | Buy |
| Ask | 4.49 |
| Volume | 5,085,719 |
| Avg. Volume (20D) | 2,164,567 |
| Open | 3.65 |
| Previous Close | 4.15 |
| Day's Range | 3.10 - 4.14 |
| 52-Week Range | 1.08 - 10.02 |
| Beta | 0.94 |
About SONN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SONN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SONN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-5.71%
Sonnet BioTherapeutics shares are trading higher a...
Unlock content with
Pro Subscription
8 months ago
-17.3%
Sonnet BioTherapeutics shares are trading lower. The company filed to sell common stock, terms not disclosed.
